Extended use of dabigatran, warfarin, or placebo in venous thromboembolism.

S. Schulman, C. Kearon, A.K. Kakkar, S. Schellong, H. Eriksson, D. Baanstra, A.M. Kvamme, J. Friedman, M.T. Nurmohamed, P. Mismetti, S.Z. Goldhaber

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)709-718
JournalNew England Journal of Medicine
Volume368
Issue number8
DOIs
Publication statusPublished - 2013

Cite this

Schulman, S., Kearon, C., Kakkar, A. K., Schellong, S., Eriksson, H., Baanstra, D., ... Goldhaber, S. Z. (2013). Extended use of dabigatran, warfarin, or placebo in venous thromboembolism. New England Journal of Medicine, 368(8), 709-718. https://doi.org/10.1056/NEJMoa1113697
Schulman, S. ; Kearon, C. ; Kakkar, A.K. ; Schellong, S. ; Eriksson, H. ; Baanstra, D. ; Kvamme, A.M. ; Friedman, J. ; Nurmohamed, M.T. ; Mismetti, P. ; Goldhaber, S.Z. / Extended use of dabigatran, warfarin, or placebo in venous thromboembolism. In: New England Journal of Medicine. 2013 ; Vol. 368, No. 8. pp. 709-718.
@article{b59ae93fbb1f41d89ae5b3fc61e3e3d8,
title = "Extended use of dabigatran, warfarin, or placebo in venous thromboembolism.",
author = "S. Schulman and C. Kearon and A.K. Kakkar and S. Schellong and H. Eriksson and D. Baanstra and A.M. Kvamme and J. Friedman and M.T. Nurmohamed and P. Mismetti and S.Z. Goldhaber",
year = "2013",
doi = "10.1056/NEJMoa1113697",
language = "Undefined/Unknown",
volume = "368",
pages = "709--718",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "8",

}

Schulman, S, Kearon, C, Kakkar, AK, Schellong, S, Eriksson, H, Baanstra, D, Kvamme, AM, Friedman, J, Nurmohamed, MT, Mismetti, P & Goldhaber, SZ 2013, 'Extended use of dabigatran, warfarin, or placebo in venous thromboembolism.' New England Journal of Medicine, vol. 368, no. 8, pp. 709-718. https://doi.org/10.1056/NEJMoa1113697

Extended use of dabigatran, warfarin, or placebo in venous thromboembolism. / Schulman, S.; Kearon, C.; Kakkar, A.K.; Schellong, S.; Eriksson, H.; Baanstra, D.; Kvamme, A.M.; Friedman, J.; Nurmohamed, M.T.; Mismetti, P.; Goldhaber, S.Z.

In: New England Journal of Medicine, Vol. 368, No. 8, 2013, p. 709-718.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Extended use of dabigatran, warfarin, or placebo in venous thromboembolism.

AU - Schulman, S.

AU - Kearon, C.

AU - Kakkar, A.K.

AU - Schellong, S.

AU - Eriksson, H.

AU - Baanstra, D.

AU - Kvamme, A.M.

AU - Friedman, J.

AU - Nurmohamed, M.T.

AU - Mismetti, P.

AU - Goldhaber, S.Z.

PY - 2013

Y1 - 2013

U2 - 10.1056/NEJMoa1113697

DO - 10.1056/NEJMoa1113697

M3 - Article

VL - 368

SP - 709

EP - 718

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 8

ER -

Schulman S, Kearon C, Kakkar AK, Schellong S, Eriksson H, Baanstra D et al. Extended use of dabigatran, warfarin, or placebo in venous thromboembolism. New England Journal of Medicine. 2013;368(8):709-718. https://doi.org/10.1056/NEJMoa1113697